Loading clinical trials...
Loading clinical trials...
This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short m...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
California Pacific Medical Center Research Institute
NCT05515757 · Amphetamine-Related Disorders
NCT01386177 · Mood Disorder, Substance-Related Disorders, and more
NCT00000351 · Amphetamine-Related Disorders
NCT00267657 · Amphetamine-Related Disorders
NCT00033072 · Amphetamine-Related Disorders
New Leaf Treatment Center
Lafayette, California
Addiction & Pharmacology Research Laboratory
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions